Whalegun
Lobbying

Outset Medical OM's latest lobbying report covers Q4 2023, at $60K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

Outset MedicalOM

Outset Medical stock page

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Outset Medical lobbying by quarter
Outset Medical lobbying by quarter
QuarterAmountReports
Q4 2022$52.4K2
Q1 2023$10K2
Q2 2023$60K1
Q3 2023$60K1
Q4 2023$60K1
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$242.4K · 7 reports
  • Medicare and Medicaid$0 · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES7 reports
  • SENATE7 reports
  • Centers For Medicare and Medicaid Services (CMS)1 reports
  • Health & Human Services, Dept of (HHS)1 reports

Firms it paid

Firm
Alston & Bird$190K4 quarters
In-houseOutset Medical$52.4K1 quarters
McDermott+$02 quarters

Former officials lobbying for it

Former position
RACHEL STAUFFER2013-2015: Health Policy Director, Rep. Diana DeGette; 2008-2011: Legislative Assistant, Senior Legislative Assistant, Rep. John TierneyQ1 2023

Lobbying reports

Filed by
24/01/22for Q4 2023Alston & Bird$60K
23/10/20for Q3 2023Alston & Bird$60K
23/07/20for Q2 2023Alston & Bird$60K
23/04/20for Q1 2023Alston & Bird$10K
23/04/18for Q1 2023McDermott+Under $5,000
23/03/28for Q1 2023Alston & BirdUnder $5,000
23/01/18for Q4 2022In-house$52.4K
23/01/17for Q4 2022McDermott+Under $5,000